These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7199148)

  • 1. Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension.
    Drukker A; Urbach J; Glaser J
    Proc Eur Dial Transplant Assoc; 1981; 18():542-7. PubMed ID: 7199148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Asymmetric hypertrophy of the intraventricular septum in normotensive patients with chronic uremia during hemodialysis therapy. M-mode echocardiographic study].
    Bernardi D; Bernini L; Cini G; Brandinelli Geri A; Bonechi I; Urti DA
    G Ital Cardiol; 1982; 12(12):847-54. PubMed ID: 6892153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertrophic obstructive cardiomyopathy in child. About two cases].
    Thiam M; Ka S; Ndiaye R; Fall PD; Mbaye FK; Imbert P
    Dakar Med; 2004; 49(3):215-7. PubMed ID: 15776621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
    Brito D; Richard P; Komajda M; Madeira H
    Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.
    Ikeda H; Maki S; Yoshida N; Murohara T; Adachi H; Koga Y; Imaizumi T
    Am J Cardiol; 1999 Apr; 83(8):1280-3, A9. PubMed ID: 10215301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil.
    Arteaga E; Ianni BM; Fernandes F; Mady C
    Am Heart J; 2005 Jun; 149(6):1099-105. PubMed ID: 15976794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in children and adolescents with chronic renal failure and end-stage renal disease.
    Drukker A
    Child Nephrol Urol; 1991; 11(3):152-8. PubMed ID: 1777894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary atypical hypertrophy: hypertrophic cardiomyopathy with acquired risk factors (author's transl)].
    Koga Y; Itaya K; Toshima H
    J Cardiogr; 1981 Dec; 11(4):1063-75. PubMed ID: 7201489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic regurgitation in hypertrophic cardiomyopathy.
    Kar AK; Roy S; Panja M
    J Assoc Physicians India; 1993 Sep; 41(9):576-8. PubMed ID: 8307914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obstructive ischemic involvement of the anterior descending coronary artery in asymmetrical septal form of hypertrophic cardiomyopathy].
    Albanesi Filho FM; Castier MB; da Silva TT; Boghossian SH; Ginefra P
    Arq Bras Cardiol; 1997 Nov; 69(5):309-15. PubMed ID: 9608997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apical hypertrophic cardiomyopathy and atrial septal defect: part of a multi-organ syndrome?
    Pattoneri P; Pelà G; Astorri E; Borghetti A
    Eur J Echocardiogr; 2007 Jun; 8(3):226-9. PubMed ID: 16542879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
    Takeda A; Takeda N
    J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy. Pathophysiology, diagnosis, and treatment.
    Popjes ED; St John Sutton M
    Geriatrics; 2003 Mar; 58(3):41-6; quiz 47. PubMed ID: 12650117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.